Effects of renal denervation at BP-elevation/reduction sites guided by renal nerve stimulation on atrial neural and structural remodeling in a hypertensive canine model
- PMID: 40640558
- DOI: 10.1038/s41440-025-02258-0
Effects of renal denervation at BP-elevation/reduction sites guided by renal nerve stimulation on atrial neural and structural remodeling in a hypertensive canine model
Abstract
Hypertension is a common condition in cardiovascular medicine, and can lead to atrial enlargement, atrial fibrosis, and even the development of atrial fibrillation. Renal denervation (RDN) causes reduction in blood pressure (BP), but its effects on hypertension-related atrial remodeling remain unclear. This study aimed to explore the effects of RDN at BP-elevation/reduction sites guided by renal nerve stimulation (RNS) on atrial neural and structural remodeling in a hypertensive canine model. The twenty-four Chinese Kunming dogs were divided into three groups: (1) the reduced BP response ablation group (RRA group, n = 8), (2) the renal stimulation control group (RSC group, n = 8), and (3) the elevated BP response ablation group (ERA group, n = 8), which were followed for 4 weeks. Our results showed that in terms of atrial neural remodeling, compared with the RSC group, the ERA group exhibited reduced tyrosine hydroxylase (TH) protein expression and a lower TH/ choline acetyltransferase (ChAT) ratio. In contrast, the RRA group showed lower ChAT and muscarinic acetylcholine receptor 2 (CM2) protein expression, and an elevated TH/ChAT ratio. Compared with the RSC group, the ERA group presented a smaller myocyte area, reduced collagen I protein expression, and lower myocardial interstitial collagen fiber content. In contrast, the RRA group presented a larger myocyte area, increased collagen I protein expression, and greater collagen fiber content. Overall, RDN at elevated BP response sites improved atrial neural and structural remodeling under hypertensive conditions, whereas RDN at reduced BP response sites exacerbated the imbalance between atrial sympathetic and parasympathetic nerve activity and worsened structural remodeling.
Keywords: Atrial remodeling; Renal denervation; Renal nerve stimulation.
© 2025. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The authors declare no competing interests. Ethics approval: This study was approved by the Animal Experiment Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University, following the guidelines of the National Institutes of Health for the care and use of laboratory animals, and standard experimental animal care was provided at the Animal Experiment Center of Chongqing Medical University.
Similar articles
-
Altered dietary salt intake for preventing diabetic kidney disease and its progression.Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3. Cochrane Database Syst Rev. 2023. PMID: 36645291 Free PMC article.
-
Sodium-Dependent Glucose Transporter-2 Inhibitor Enhances the Hypotensive Effect of Renal Denervation by Inhibiting Sympathetic Activity and Inflammatory Reaction.Front Biosci (Landmark Ed). 2025 Jun 30;30(6):31309. doi: 10.31083/FBL31309. Front Biosci (Landmark Ed). 2025. PMID: 40613280
-
Renal denervation for resistant hypertension.Cochrane Database Syst Rev. 2017 Feb 21;2(2):CD011499. doi: 10.1002/14651858.CD011499.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD011499. doi: 10.1002/14651858.CD011499.pub3. PMID: 28220472 Free PMC article. Updated.
-
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease.Clin Kidney J. 2025 Jun 18;18(7):sfaf184. doi: 10.1093/ckj/sfaf184. eCollection 2025 Jul. Clin Kidney J. 2025. PMID: 40625696 Free PMC article.
-
Renal denervation for atrial fibrillation: a comprehensive updated systematic review and meta-analysis.J Hum Hypertens. 2022 Oct;36(10):887-897. doi: 10.1038/s41371-022-00658-0. Epub 2022 Jan 29. J Hum Hypertens. 2022. PMID: 35094013 Free PMC article.
References
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–72. - PubMed
-
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71:1269–324. - PubMed
-
- DiBona GF, Esler M. Translational medicine: The antihypertensive effect of renal denervation. Am J Physiol Regulatory, Integr Comp Physiol 2010;298:R245–53.
-
- Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81. - PubMed
-
- Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): A randomised controlled trial. Lancet. 2010;376:1903–9. - PubMed
LinkOut - more resources
Full Text Sources